Popular Articles

Prevalence Of Painful Bladder Syndrome (PBS) Symptoms In Adult Women In The General Population In Japan
UroToday.com - In the only survey of BPS/IC conducted in Japan, done in urology clinics, the prevalence was estimated at 4.5/100,000 women.[Ito et al. 2000] Studies in Finland, Austria, and Taiwan using O"Leary-Sant questionnaires to identify persons with symptoms of BPS/IC have arrived at figures around 300/100,000 women.[Yu 2006;Leppilahti . 2005;Temml et al. 2007]

Slight Majority Of U.S. Residents Call Themselves 'Pro-life;' 76% Say Abortion Should Be Legal, Poll Shows
Seventy-six percent of U.S. residents believe that abortion should be legal, a finding in keeping with public opinion over the past three decades, according to a Gallup poll released on Saturday, the AP/Boston Globe reports (AP/Boston Globe, 5/16). However, 51% of respondents identified themselves as "pro-life," while 42% said they are "pro-choice" (Gallup poll, 5/16). The finding marks the first time since Gallup began asking about abortion rights in 1995 that a majority of respondents said they consider themselves "pro-life" (Nadeau, Boston Herald, 5/16). Last year"s poll showed that 50% of respondents consider themselves "pro-choice," compared with 44% who said they are "pro-life" (Abcarian, Los Angeles Times, 5/16).The new poll found that 53% of respondents believe abortion should be legal under some circumstances, 23% believe it should be legal under any circumstances and 22% believe it should be illegal under any circumstances (Boston Herald, 5/16). The percentage of respondents who oppose abortion rights in all cases rose slightly from last year, while those who support abortion rights in all cases decreased slightly. The Los Angeles Times reports that the percentage of respondents who oppose abortion rights in all circumstances and those who support abortion rights in all circumstances is "a virtual tie." The results have a margin of sampling error of plus or minus three percentage points.Respondents who labeled themselves as moderates and Republicans accounted for most of the change in views compared with past polls, as Democrats" views remained consistent with previous years, according to the Los Angeles Times. Gallup in its analysis wrote that it is "possible" that President Obama "has pushed the public"s understanding of what it means to be "pro-choice" slightly to the left, politically" (Los Angeles Times, 5/16). The survey was conducted between May 7 and May 10 (AP/Boston Globe, 5/16).Nancy Keenan, president of NARAL Pro-Choice America, said, "I am pretty confident that Americans really don"t want Roe v. Wade overturned." She added that the increase in respondents identifying as "pro-life" does not "square with what has happened in the last several elections," noting that voters have rejected several antiabortion-rights ballot measures in South Dakota, California, Oregon and Colorado since 2005. However, Charmaine Yoest, president of Americans United for Life, said, "It tracks pretty much with what we"ve always known: People generally are pro-life depending on how you ask the question" (Los Angeles Times, 5/16).
News of the day
Osteoporosis Drug Heritage Continues Ahead Of 10th Anniversary
Data presented today at the 8th European Congress on Menopause
Sexual Health

Radiofrequency Ablation Is Effective Treatment For Barrett's Esophagus

A landmark clinical trial led by a University of North Carolina at Chapel Hill researcher concludes that radiofrequency ablation is an effective treatment for dysplasia in people with Barrett"s esophagus, a condition that can lead to deadly gastrointestinal cancer. "These results show there is a substantial difference between treatment with radiofrequency ablation and a placebo or "sham" treatment," said Nicholas Shaheen, M.D., principal investigator of the study, associate professor in the UNC School of Medicine and the UNC Gillings School of Public Health and director of UNC"s Center for Esophageal Diseases and Swallowing. "It"s a strongly positive finding." The study is published in the May 28, 2009 issue of The New England Journal of Medicine. Barrett"s esophagus is a condition in which repeated acid reflux causes the cells that normally line the esophagus to be replaced by a different type of cell, similar to those normally found in the intestines. This process is called intestinal metaplasia. By itself Barrett"s is not a life-threatening problem, but a small percentage of people with Barrett"s will develop esophageal adenocarcinoma, an especially deadly form of cancer. Radiofrequency ablation (RFA), a non-invasive technique that uses thermal energy, or heat, to destroy cells, is very effective at destroying abnormal cells in the esophagus. The new UNC-led study is the first randomized trial to evaluate radiofrequency ablation for treating dysplasia, a more advanced stage of Barrett"s esophagus in which the abnormal cells acquire precancerous traits. The RFA system used in the study uses thermal energy provided by a set of electromagnetic coils on the surface of a balloon, Shaheen said. "The balloon is placed in the area of the esophagus where the offending cells are and the balloon is inflated. Energy is then passed through the electromagnetic coils and, because we know how far apart the coils are spaced and how much energy is being put through them, we get a very reliable depth of burn, such that you can kill the abnormal cells on the inner surface without damaging the whole organ." In the study, 127 people were randomized to receive either radiofrequency ablation or a simulated, "sham" version of the procedure at one of 19 participating medical centers. Among those with low grade dysplasia who received radiofrequency ablation, 90.5 percent were free of dysplasia 12 months after treatment, compared to 22.7 percent in those who received the sham procedure. Among those with high grade dysplasia, 81 percent who received radiofrequency ablation had complete eradication of intestinal metaplasia, compared to 19 percent in the sham group. Overall, 77.4 percent of study participants treated with RFA had complete eradication of intestinal metaplasia, compared to 2.3 percent in the sham group. There was also less progression towards disease in the RFA group, 3.6 percent vs. 16.3 percent, and significantly more sham subjects developed esophageal adenocarcinoma, 9.3 percent vs. 1.2 percent. The study concluded that RFA demonstrated a high rate of eradication of dysplasia and intestinal metaplasia and that these changes reduced the risk of progression towards dysplasia and the risk of developing cancer. Funding for the study was provided by BARRX Medical Inc., which manufactures the HALO360 radiofrequency ablation system used in the study, the Investigator-Sponsored Study Program of AstraZeneca and a grant from the National Institutes of Health. University of North Carolina at Chapel Hill School of Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):